Oncology PracticeAre Food Emulsifiers Associated With Increased Cancer Risk?February 23, 2024Preventive CareBreast CancerPatient & Survivor CareGastrointestinal CancerGastroenterologyGenitourinary CancerCNS/Brain Cancer
Oncology PracticeDemocratic Lawmakers Press Pfizer on Chemotherapy Drug ShortagesFebruary 22, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastroenterologyGastrointestinal Cancer
Oncology PracticeUnleashing Our Immune Response to Quash CancerFebruary 21, 2024Immuno-oncologyGene TherapyMixed TopicsPatient & Survivor CarePediatricsAggressive LymphomasALL
Hematology NewsBelantamab Mafodotin Tops Daratumumab in Multiple MyelomaFebruary 13, 2024Multiple Myeloma
Hematology NewsNew Multiple Myeloma Staging Systems Outperform the StandardDecember 20, 2023Multiple Myeloma
Hematology NewsIn Transplant-Ineligible Myeloma, This Frontline Tx Is BetterDecember 15, 2023Multiple MyelomaTransplant
Hematology NewsNo Benefit to Salvage Transplant in R/R Multiple MyelomaDecember 14, 2023Multiple MyelomaTransplant
Hematology NewsDistinct toxicity profiles for anti-BCMA myeloma therapiesDecember 12, 2023Multiple MyelomaCellular Therapy
Hematology NewsMyeloma: Isatuximab Four-Drug Regimen Boosts MRD NegativityDecember 11, 2023Multiple Myeloma
Hematology NewsIn real world, patients with myeloma have worse outcomesDecember 11, 2023Multiple Myeloma
Hematology NewsASH 2023: Equity, Sickle Cell, and Real-Life OutcomesDecember 4, 2023Mixed TopicsBleeding DisordersAMLThrombosisTransplantMultiple MyelomaMyelodysplastic Syndrome
Hematology NewsFDA OKs new agent to block chemotherapy-induced neutropeniaNovember 29, 2023Mixed TopicsAggressive LymphomasB Cell LymphomaDLBCLHodgkin LymphomaIndolent LymphomaMantle Cell Lymphoma
Hematology NewsFDA panel voices concerns over 2 lymphoma accelerated approvalsNovember 17, 2023T Cell LymphomasMixed TopicsALLAggressive LymphomasB Cell LymphomaCLLAML
